State Street Corp ALNYLAM PHARMACEUTICALS INC Transaction History

State Street Corp

  • $2.59 Trillion
  • Q2 2025
Number of Shares
19,920,000
Previous 21,445,000 7.11%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-1,525,000 Reduced 7.11%
19,920,000 $0
Q1 2025

May 15, 2025
SELL
N/A
-1,713,000 Reduced 7.4%
21,445,000 $0
Q4 2024

Feb 14, 2025
BUY
N/A
1,400,000 Added 6.43%
23,158,000 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-350,000 Reduced 1.58%
21,758,000 $0
Q2 2024

Aug 14, 2024
BUY
N/A
250,000 Added 1.14%
22,108,000 $0
Q1 2024

May 15, 2024
SELL
N/A
-1,100,000 Reduced 4.79%
21,858,000 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-200,000 Reduced 0.86%
22,958,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
23,158,000 New
23,158,000 $0
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email